Tinzaparin
Showing 51 - 75 of 227
Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary
Recruiting
- Pulmonary Embolism
- Tissue Plasminogen Activator, Alteplase
- Low-molecular weight heparin
-
İzmir, Bornova/İzmir, TurkeyEge University
Aug 22, 2022
Esophageal Tumors, Thrombosis, Thromboembolism Trial in Aarhus N (Fragmin 5000 UNT in 0.2 ML Prefilled Syringe)
Recruiting
- Esophageal Neoplasms
- +2 more
- Fragmin 5000 UNT in 0.2 ML Prefilled Syringe
-
Aarhus N, DenmarkThrombosis and Haemostasis Research Unit, Department for Clinica
Sep 23, 2021
Venous Thrombosis, Tumors Trial in Minneapolis, Columbus, Milwaukee (Heparin, Low-Molecular-Weight, or direct oral
Completed
- Venous Thrombosis
- Neoplasms
- Heparin, Low-Molecular-Weight, or direct oral anticoagulants
-
Minneapolis, Minnesota
- +2 more
Apr 26, 2022
Hepatic Artery Thrombosis, Liver Transplant; Complications, Pediatric Disease Trial in Shanghai (Ticagrelor Oral Tablet
Not yet recruiting
- Hepatic Artery Thrombosis
- +2 more
- Ticagrelor Oral Tablet [Brilinta]
- Low molecular weight heparin
-
Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 23, 2021
Venous Thromboembolism, Cancer Trial in Aachen (Rivaroxaban, low-molecular heparine)
Terminated
- Venous Thromboembolism
- Cancer
- Rivaroxaban
- low-molecular heparine
-
Aachen, GermanyUniklinik
Apr 28, 2021
Adenomyosis, Assisted Reproductive Technology Trial in Nanjing (Low molecular weight heparin)
Active, not recruiting
- Adenomyosis
- Assisted Reproductive Technology
- Low molecular weight heparin
-
Nanjing, Jiangsu, ChinaReproductive Medicine Center, The affiliated Drum Towel Hospital
Feb 3, 2021
COVID-19 Acute Respiratory Distress Syndrome, Hypoxemia Trial in Istanbul (Inhaled Low molecular weight heparin, Standard
Completed
- COVID-19 Acute Respiratory Distress Syndrome
- Hypoxemia
- Inhaled Low molecular weight heparin
- Standard Treatment
-
Istanbul, Fatih, TurkeyIstanbul University Medical Faculty
Aug 3, 2021
Pulmonary Embolism, Pulmonary Thromboembolisms, Embolism, Pulmonary Trial in Tehran (Conventional catheter-directed thrombolysis
Terminated
- Pulmonary Embolism
- +3 more
- Conventional catheter-directed thrombolysis (CDT) with recombinant tissue plasminogen activator (rtPA)
- Enoxaparin
-
Tehran, Iran, Islamic Republic ofRajaie Cardiovascular Medical and Research Center
Dec 28, 2021
Subsegmental Pulmonary Embolism Nos Trial in Redhill (No treatment, Warfarin, direct oral anticoagulants)
Recruiting
- Subsegmental Pulmonary Embolism Nos
- No treatment
- +3 more
-
Redhill, United KingdomSurrey & Sussex Healthcare NHS Trust
Sep 28, 2021
Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO
Completed
- COVID-19
- Hypercoagulability
- Low Molecular Weight Heparin
-
Padova, ItalyGiuseppe Camporese
Mar 17, 2021
Pulmonary Embolism, Thoracic Surgery Trial in Shanghai (Chemoprophylaxis with Low Molecular Weight Heparin (LMWH))
Completed
- Pulmonary Embolism
- Thoracic Surgery
- Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 5, 2021
Pneumonia, Viral, Cytokine Storm Trial in Madrid, Valencia (radiation, device, drug)
Suspended
- Pneumonia, Viral
- Cytokine Storm
- Ultra-Low-dose radiotherapy
- +8 more
-
Madrid, Spain
- +1 more
Mar 14, 2022
Acute Coronary Syndromes Trial in Brighton (Conservative Arm, Invasive Arm)
Completed
- Acute Coronary Syndromes
- Conservative Arm
- Invasive Arm
-
Brighton, United KingdomRoyal Sussex County Hospital
Jan 26, 2021
Cardiovascular Diseases, COVID-19 Trial in Boston (Enoxaparin)
Recruiting
- Cardiovascular Diseases
- COVID-19
-
Boston, MassachusettsAbdurahman Khalil
Feb 4, 2022
Pneumonia, Viral Trial in Reus, Barcelona, Madrid (radiation, drug, device)
Recruiting
- Pneumonia, Viral
- Low-dose radiotherapy
- +7 more
-
Reus, Tarragona, Spain
- +2 more
Jul 29, 2021
Cerebral Venous Thrombosis Trial in Canada (Rivaroxaban, Standard of care)
Recruiting
- Cerebral Venous Thrombosis
- Rivaroxaban
- Standard of care
-
Calgary, Alberta, Canada
- +12 more
Sep 27, 2021
Pharmacogenomics of Heparin-Induced Thrombocytopenia
Recruiting
- Heparin-induced Thrombocytopenia
- Blood Draw
-
Tucson, ArizonaBanner University Medical Center - Tucson
Apr 26, 2021
Unsuspected Pulmonary Embolism in Cancer Patients
Completed
- Unsuspected Pulmonary Embolism
- Heparin, fondaparinux, vitamin-K antagonists, aspirin
-
Washington, District of Columbia
- +45 more
Aug 7, 2019
Restart Anticoagulation in Spontaneous Intracerebral Hemorrhage
Unknown status
- Cerebral Hemorrhage
- Low molecular weight heparin
-
Hangzhou, Zhejiang, China
- +1 more
Jun 26, 2020
VTE and Higher Hypercoagulability in Patients Recovered in ICU
Completed
- COVID-19 Disease
- Thromboembolism, Venous
- thromboprophylaxis with low-molecular-weight heparin or fondaparinux
-
Padova, ItalyGiuseppe Camporese
Sep 15, 2020
Coronavirus Disease (COVID)19 Trial in Cairo (low-molecular-weight heparin)
Unknown status
- Coronavirus Disease (COVID)19
- low-molecular-weight heparin
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Oct 10, 2020
Cancer, Thrombosis, Venous Thromboembolism Trial in United Kingdom (Low Molecular Weight Heparin (LMWH))
Terminated
- Cancer
- +4 more
- Low Molecular Weight Heparin (LMWH)
-
Nuneaton, Warwickshire, United Kingdom
- +4 more
Oct 25, 2018
Cancer, Venous Thromboembolism, Obesity Trial in Canada (Dalteparin)
Recruiting
- Cancer
- +2 more
- Dalteparin
-
Edmonton, Alberta, Canada
- +4 more
Jan 12, 2021